Today's Hours: 12:00pm - 8:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda, editors.
    Summary: This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.

    Contents:
    1 Overview.-2 Lung cancer.-3 Breast cancer
    4 Head and neck cancer.-5 Gastrointestinal cancer including GIST
    6 Pancreatic cancer
    7 Urological cancer
    8 Malignant bone and soft tissue tumors
    9 Skin cancer including malignant melanoma
    10 Malignant lymphoma.
    Digital Access Springer 2021
  • Journal
    Print 19571979
  • Article
    Hoffmann MK.
    J Immunol. 1978 Aug;121(2):619-21.
    Serum from C3H/HeJ mice in contrast to serum from other mouse strains does not convert EA into EAC. A factor in supportive serum permits nonsupportive C3H/HeJ serum to produce a functional EAC-rosetting reagent. This factor is heat stable. Its concentration in serum parallels the sensitivity of mice to LPS. It is absent or inoperative when sensitivity is reduced on a genetic basis and increased when sensitivity is increased by treatment with BCG.
    Digital Access Access Options